These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38188730)

  • 1. Retracted: Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma.
    International BR
    Biomed Res Int; 2023; 2023():9869137. PubMed ID: 38188730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma.
    Jing H; Yang F; Peng K; Qin D; He Y; Yang G; Zhang H
    Biomed Res Int; 2022; 2022():4667117. PubMed ID: 36246986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoprogression in high-grade glioma.
    Knudsen-Baas KM; Moen G; Fluge Ø; Storstein A
    Acta Neurol Scand Suppl; 2013; (196):31-7. PubMed ID: 23190289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression.
    Shi W; Qu C; Wang X; Liang X; Tan Y; Zhang H
    Eur J Radiol; 2021 Nov; 144():109941. PubMed ID: 34735828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
    Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
    Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
    Wu XF; Liang X; Wang XC; Qin JB; Zhang L; Tan Y; Zhang H
    Eur J Radiol; 2021 Feb; 135():109445. PubMed ID: 33341429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients.
    Baine M; Burr J; Du Q; Zhang C; Liang X; Krajewski L; Zima L; Rux G; Zhang C; Zheng D
    J Imaging; 2021 Jan; 7(2):. PubMed ID: 34460616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9761763. PubMed ID: 37503375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
    Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
    J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
    Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
    Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
    Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
    Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
    J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of low- and high-grade gliomas using radiomic analysis of multiple sequences of MRI brain.
    Zachariah RM; Priya PS; Pendem S
    J Cancer Res Ther; 2023; 19(2):435-446. PubMed ID: 37313916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Evaluation of the Risk of Recurrence in Patients with Local Advanced Rectal Tumours by Different Radiomic Analysis Approaches.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9754194. PubMed ID: 38075095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
    Tang TY; Li X; Zhang Q; Guo CX; Zhang XZ; Lao MY; Shen YN; Xiao WB; Ying SH; Sun K; Yu RS; Gao SL; Que RS; Chen W; Huang DB; Pang PP; Bai XL; Liang TB
    J Magn Reson Imaging; 2020 Jul; 52(1):231-245. PubMed ID: 31867839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
    Oncology JO
    J Oncol; 2023; 2023():9832716. PubMed ID: 37476550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
    Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
    Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas.
    Pei D; Guan F; Hong X; Liu Z; Wang W; Qiu Y; Duan W; Wang M; Sun C; Wang W; Wang X; Guo Y; Wang Z; Liu Z; Xing A; Guo Z; Luo L; Liu X; Cheng J; Zhang B; Zhang Z; Yan J
    Eur Radiol; 2023 May; 33(5):3455-3466. PubMed ID: 36853347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.